2seventy Bio Stock Net Income
| TSVTDelisted Stock | USD 5.00 0.00 0.00% |
Relative to fundamental indicators, the technical analysis model gives you tools to check practical technical drivers of 2Seventy Bio, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from 2Seventy Bio's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting 2Seventy Bio's valuation are summarized below:2Seventy Bio does not now have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. 2Seventy |
Search Suggestions
| TS | Tenaris SA ADR | Company |
| TSAMX | Thornburg Summit | Mutual Fund |
| TSI | TCW Strategic Income | ETF |
| TSL | TSL | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, 2Seventy Bio reported net income of (57.25 Million). This is 116.77% lower than that of the Biotechnology sector and 181.73% lower than that of the Health Care industry. The net income for all United States stocks is 110.03% higher than that of the company.
2Seventy Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 2Seventy Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 2Seventy Bio could also be used in its relative valuation, which is a method of valuing 2Seventy Bio by comparing valuation metrics of similar companies.2Seventy Bio is currently under evaluation in net income category among its peers.
2Seventy Fundamentals
| Return On Equity | -0.0194 | |||
| Return On Asset | -0.0749 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 335.53 M | |||
| Shares Outstanding | 53.23 M | |||
| Shares Owned By Insiders | 6.44 % | |||
| Shares Owned By Institutions | 82.40 % | |||
| Number Of Shares Shorted | 2.59 M | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 5.50 X | |||
| Revenue | 37.86 M | |||
| Gross Profit | (13.24 M) | |||
| EBITDA | (115.43 M) | |||
| Net Income | (57.25 M) | |||
| Cash And Equivalents | 357.93 M | |||
| Cash Per Share | 9.45 X | |||
| Total Debt | 243.72 M | |||
| Debt To Equity | 0.73 % | |||
| Current Ratio | 3.88 X | |||
| Book Value Per Share | 4.08 X | |||
| Cash Flow From Operations | (85 M) | |||
| Short Ratio | 2.44 X | |||
| Earnings Per Share | (0.08) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 65 | |||
| Beta | 1.05 | |||
| Market Capitalization | 266.14 M | |||
| Total Asset | 479.51 M | |||
| Retained Earnings | (568.46 M) | |||
| Working Capital | 147.16 M | |||
| Net Asset | 479.51 M |
About 2Seventy Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 2Seventy Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 2Seventy Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 2Seventy Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in 2Seventy Stock
If you are still planning to invest in 2Seventy Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 2Seventy Bio's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |